SART3 anticorps (C-Term)
-
- Antigène Voir toutes SART3 Anticorps
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SART3 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Séquence
- MSNADFAKLF LRK
- Purification
- Affinity purification
- Immunogène
- C-terminal
- Isotype
- IgG
- Top Product
- Discover our top product SART3 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin. Aliquot and store at -20 °C. Minimize freezing and thawing.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
-
- Antigène
- SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
- Autre désignation
- SART3 (SART3 Produits)
- Synonymes
- anticorps SART3, anticorps DKFZp469J2418, anticorps si:ch211-191d15.4, anticorps wu:fc51h03, anticorps DSAP1, anticorps P100, anticorps RP11-13G14, anticorps TIP110, anticorps p110, anticorps p110(nrb), anticorps AU045857, anticorps mKIAA0156, anticorps squamous cell carcinoma antigen recognized by T-cells 3, anticorps squamous cell carcinoma antigen recognized by T-cells 3 L homeolog, anticorps squamous cell carcinoma antigen recognized by T cells 3, anticorps SART3, anticorps sart3, anticorps sart3.L, anticorps Sart3
- Pathways
- Ribonucleoprotein Complex Subunit Organization
-